0001725160-24-000163.txt : 20241004 0001725160-24-000163.hdr.sgml : 20241004 20241004180121 ACCESSION NUMBER: 0001725160-24-000163 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241004 FILED AS OF DATE: 20241004 DATE AS OF CHANGE: 20241004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vultaggio Vincent CENTRAL INDEX KEY: 0002018766 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39263 FILM NUMBER: 241355839 MAIL ADDRESS: STREET 1: C/O ZENTALIS PHARMACEUTICALS, INC. STREET 2: 530 SEVENTH AVENUE, SUITE 2201 CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zentalis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001725160 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 823607803 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10275 SCIENCE CENTER DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 263-4333 MAIL ADDRESS: STREET 1: 10275 SCIENCE CENTER DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Zentalis Pharmaceuticals, LLC DATE OF NAME CHANGE: 20200107 FORMER COMPANY: FORMER CONFORMED NAME: Zeno Pharma, LLC DATE OF NAME CHANGE: 20171212 4 1 wk-form4_1728079274.xml FORM 4 X0508 4 2024-10-04 0 0001725160 Zentalis Pharmaceuticals, Inc. ZNTL 0002018766 Vultaggio Vincent C/O ZENTALIS PHARMACEUTICALS, INC. 10275 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 0 1 0 0 Principal Accounting Officer 1 Common Stock 2024-10-04 4 S 0 1603 3.18 D 33855 D A portion of the shares were sold automatically to satisfy withholding tax obligations upon the vesting of restricted stock units, and the remainder of the shares were sold pursuant to a Rule 10b5-1 instruction adopted by the Reporting Person on September 20, 2023. /s/ Andrea Paul, attorney-in-fact for Vincent Vultaggio 2024-10-04